Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NASDAQ:NBIX

Overview | Financials
Company Name Neurocrine Biosciences, Inc.
Symbol NBIX
Currency USD
Price 143.8
Market Cap 14,262,299,700
Dividend Yield 0%
52-week-range 84.23 - 154.61
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Kevin C. Gorman Ph.D.
Website https://www.neurocrine.com

An error occurred while fetching data.

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive

Related Stocks

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

14.21 USD

Repligen Corporation logo

Repligen Corporation

RGEN

120.7 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

53.89 USD

Bruker Corporation logo

Bruker Corporation

BRKR

30.8 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

2.44 USD

NovoCure Limited logo

NovoCure Limited

NVCR

12.6 USD

Masimo Corporation logo

Masimo Corporation

MASI

148.79 USD

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

129.85 USD

Financials

Numbers are in millions USD

Numbers are in millions USD